152 related articles for article (PubMed ID: 10859510)
1. Melanoma-associated retinopathy versus abnormal retinal function due to interferon-alpha/Isotretinoin therapy in cutaneous malignant melanoma.
Feigl B; Faschinger C; Soyer P
Ophthalmologica; 2000; 214(4):271-6. PubMed ID: 10859510
[TBL] [Abstract][Full Text] [Related]
2. Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.
Richtig E; Soyer HP; Posch M; Mossbacher U; Bauer P; Teban L; Svolba G; Wolf IH; Fritsch P; Zelger B; Volc-Platzer B; Gebhart W; Mischer P; Steiner A; Pachinger W; Hintner H; Gschnait F; Rappersberger K; Pilarski P; Pehamberger H;
J Clin Oncol; 2005 Dec; 23(34):8655-63. PubMed ID: 16260701
[TBL] [Abstract][Full Text] [Related]
3. Unilateral manifestation of melanoma-associated retinopathy.
Janáky M; Pálffy A; Kolozsvári L; Benedek G
Arch Ophthalmol; 2002 Jun; 120(6):866-7. PubMed ID: 12049605
[No Abstract] [Full Text] [Related]
4. [Melanoma-associated retinopathy. Apropos of a case and review of the literature].
Bret-Dibat C; Rougier MB; Le Rebeller MJ; Delaunay M
Bull Cancer; 1996 Dec; 83(12):1019-22. PubMed ID: 9116366
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous melanoma-associated retinopathy with retinal periphlebitis.
Remulla JF; Pineda R; Gaudio AR; Milam AH
Arch Ophthalmol; 1995 Jul; 113(7):854-5. PubMed ID: 7605271
[No Abstract] [Full Text] [Related]
6. 'On' response defect in paraneoplastic night blindness with cutaneous malignant melanoma.
Alexander KR; Fishman GA; Peachey NS; Marchese AL; Tso MO
Invest Ophthalmol Vis Sci; 1992 Mar; 33(3):477-83. PubMed ID: 1544774
[TBL] [Abstract][Full Text] [Related]
7. [Ocular complications of adjuvant interferon therapy for malignant melanoma: a review].
Ockenfels M; Lisch W
Hautarzt; 2003 Feb; 54(2):144-7. PubMed ID: 12590309
[TBL] [Abstract][Full Text] [Related]
8. Node way out.
Vaphiades MS; Brown H; Whitcup SM
Surv Ophthalmol; 2000; 45(1):77-83. PubMed ID: 10946083
[TBL] [Abstract][Full Text] [Related]
9. Severe course of cutaneous melanoma associated paraneoplastic retinopathy.
Kellner U; Bornfeld N; Foerster MH
Br J Ophthalmol; 1995 Aug; 79(8):746-52. PubMed ID: 7547786
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous melanoma-associated retinopathy.
Kim RY; Retsas S; Fitzke FW; Arden GB; Bird AC
Ophthalmology; 1994 Nov; 101(11):1837-43. PubMed ID: 7800366
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic night blindness with malignant melanoma.
Berson EL; Lessell S
Am J Ophthalmol; 1988 Sep; 106(3):307-11. PubMed ID: 2971322
[TBL] [Abstract][Full Text] [Related]
12. Full-field electroretinogram in a patient with cutaneous melanoma-associated retinopathy.
Andréasson S; Ponjavic V; Ehinger B
Acta Ophthalmol (Copenh); 1993 Aug; 71(4):487-90. PubMed ID: 8249579
[TBL] [Abstract][Full Text] [Related]
13. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
Karatsai E; Robson AG; Taylor SRJ
JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to transducin in a patient with melanoma-associated retinopathy.
Potter MJ; Adamus G; Szabo SM; Lee R; Mohaseb K; Behn D
Am J Ophthalmol; 2002 Jul; 134(1):128-30. PubMed ID: 12095824
[TBL] [Abstract][Full Text] [Related]
15. Unusual aspects of melanoma. Case 3. Melanoma-associated retinopathy presenting with night blindness.
Myers DA; Bird BR; Ryan SM; Tormey P; McKenna P; OReilly S; Breathnach OS
J Clin Oncol; 2004 Feb; 22(4):746-8. PubMed ID: 14966102
[No Abstract] [Full Text] [Related]
16. [Bilateral retinal microangiopathy in interferon therapy of malignant melanoma of the skin].
Neubauer AS; Hoops JP
Klin Monbl Augenheilkd; 2000 Nov; 217(5):308-11. PubMed ID: 11146832
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic retinopathy associated with metastatic cutaneous melanoma of unknown primary site.
Kiratli H; Thirkill CE; Bilgiç S; Eldem B; Keçeci A
Eye (Lond); 1997; 11 ( Pt 6)():889-92. PubMed ID: 9537153
[TBL] [Abstract][Full Text] [Related]
18. Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanoma.
Pföhler C; Haus A; Palmowski A; Ugurel S; Ruprecht KW; Thirkill CE; Tilgen W; Reinhold U
Br J Dermatol; 2003 Jul; 149(1):74-8. PubMed ID: 12890197
[TBL] [Abstract][Full Text] [Related]
19. [Melanoma-associated retinopathy in a patient without a primary tumour].
Diamant PM; Prause JU; Rosenberg T; Fledelius HC
Ugeskr Laeger; 2004 Aug; 166(33):2812-3. PubMed ID: 15344864
[No Abstract] [Full Text] [Related]
20. [Paraneoplastic retinopathy associated with cutaneous melanoma. An update apropos of a case].
Rougier MB; Hostyn P; Bret-Dibat C; Delaunay MM; Riss I; Le Rebeller MJ
J Fr Ophtalmol; 1995; 18(5):396-403. PubMed ID: 7560778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
